Cargando…
Treatment of ischemic stroke with modified mesenchymal stem cells
Ischemic stroke is one of the leading causes of death and disability. Ischemia triggers a cascade of events leading to cell death and cerebral infarction. Mesenchymal stem cell (MSC) therapy is a promising treatment modality to promote the development of nerve and blood vessels and improve nerve fun...
Autores principales: | Chen, Hao, Zhou, Liangfu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339408/ https://www.ncbi.nlm.nih.gov/pubmed/35919816 http://dx.doi.org/10.7150/ijms.74161 |
Ejemplares similares
-
Mesenchymal stem cells in the treatment of ischemic stroke: progress and possibilities
por: Doeppner, Thorsten R, et al.
Publicado: (2010) -
Progress in Mesenchymal Stem Cell Therapy for Ischemic Stroke
por: Guo, Yinghan, et al.
Publicado: (2021) -
Transplanting Mesenchymal Stem Cells for Treatment of Ischemic Stroke
por: Wang, Fan, et al.
Publicado: (2018) -
Potential mechanisms and therapeutic targets of mesenchymal stem cell transplantation for ischemic stroke
por: Zhou, Li, et al.
Publicado: (2022) -
Immunomodulation: The next target of mesenchymal stem cell-derived exosomes in the context of ischemic stroke
por: Shan, Xiao-Qian, et al.
Publicado: (2023)